Is it IBS or MCAS?
By BeatSIBO editorial team · Updated August 6, 2026
At a glance
Scope
IBS
Gut only, by definition
MCAS
Multi-system, by definition
How it is reached
IBS
Symptom criteria plus exclusion
MCAS
Published criteria, which specialists dispute
Confirmatory test
IBS
None
MCAS
Mediator measurement, strict sample handling
The question to ask
IBS
What is my gut doing
MCAS
Do my symptoms leave the gut
The one that matters: If your symptoms leave the gut, that observation matters more here than any symptom list.
Most pages on this pair compare gut symptoms, which is the least informative comparison available, because the gut symptoms are the part that matches.
What actually separates them
The short answer
IBS is a gut diagnosis, defined by symptom pattern and duration after other causes are excluded. Mast cell activation syndrome is systemic by definition, involving mediator release that affects multiple organ systems. So the useful question is not what your gut is doing. It is whether anything outside the gut is doing it at the same time.
Flushing, hives, unexplained blood pressure changes, or reactions that involve skin and airway alongside the gut point away from a purely gut explanation. That is not a diagnosis, it is a reason to widen the investigation.
Why an IBS label can be accurate and incomplete
The short answer
IBS is a diagnosis of exclusion, which means it describes what remains after other causes were ruled out. If the exclusion work did not cover what you actually have, the label was accurate as far as it went and is not the whole picture. That is a different situation from a wrong diagnosis, and it calls for a different conversation.
This distinction matters practically. Arriving at an appointment saying the previous diagnosis was wrong invites a defence of it. Arriving with a record of symptoms that sit outside what that diagnosis covers invites an investigation.
What is not settled here
The mast cell criteria are genuinely disputed. Two published criteria sets are in active use and they do not agree about who qualifies, so a person can meet one and fail the other. We are not going to pick one for you, and a site that does while also selling something is worth reading carefully.
What the guideline says about reasoning from symptoms
Pimentel M et al., American Journal of Gastroenterology 2020 Clinical guidelineNo single symptom can be specifically attributed to bacterial overgrowth, which is the condition in this space with an actual test. That sets a ceiling on how far symptom-matching can take anyone, and it applies with more force to a pair where one member has no test at all.
What to do next
Record what happens outside the gut, and when, relative to meals and anything else you can identify. That record is the thing a clinician cannot reconstruct in a short appointment, and it is more likely to change what gets investigated than any argument about which label fits.
Common questions
- How is MCAS confirmed?
- By mediator measurements taken during or shortly after a reaction, with strict sample handling, alongside symptom criteria and response to treatment. Two competing criteria sets are in active use and disagree about who qualifies, so a person can meet one and not the other.
- Does it tell me anything if antihistamines help?
- Less than people expect. Feeling better on something that blocks histamine is consistent with several explanations, and neither published criteria set accepts a response on its own as confirmation. It is worth reporting because it is part of your history. It is not a test, and reasoning backwards from a response to a diagnosis is how a lot of confident wrong answers get made.
- Which kind of specialist deals with this?
- Usually different ones, which is part of the difficulty. Gut symptoms tend to route to gastroenterology, while mast cell criteria sit with allergy and immunology. People with symptoms in both places often move between the two without either holding the whole picture. Knowing that in advance makes it easier to ask directly who is taking the overall question.
